A Finnish study transformed daycare playgrounds into biodiverse natural habitats, replacing traditional equipment with soil, plants, and fo...

Net margin is a useful metric. It tells you how much profit remains after costs, interest, and tax are deducted from revenue. But it does n...

Over the next few sessions, as the uncertainty caused by the Gulf war intensifies and makes you anxious, remember this: It is not the first...

The United States has temporarily closed its southern border to livestock imports due to the northward spread of the New World screwworm fl...

ICMR has conducted a groundbreaking study on male contraception and found that a non-hormonal injectable contraceptive called RISUG is both...

Cenexi, along with its subsidiaries, is engaged primarily in the business of Contract Development & Manufacturing Organisation (CDMO) of ph...

The state-run WAM news agency announced late Thursday the lockdown would begin Monday and last each day from 12 a.m. to 5 a.m. It comes jus...

The campaign over the past four years in the far west region of Xinjiang is leading to what some experts are calling a form of "demographic...

Sun Pharma, Lupin and others are falling apart on injectable inspections and this is where the problem starts.

"Non-sterile plants getting stuck for such a long time are really surprising."

Concern remains over Indian pharma’s sterile manufacturing practices, says Prosfora Tech MD

The pressing need to absorb both dollar and rupee liquidity is already stretching the Reserve Bank of India’s range of tools and complicati...

Swedish contract drug manufacturing firm Recipharm has acquired a 74% stake in Nitin Lifesciences, a privately held sterile injectables man...

Drugs Technical Advisory Board's recommendations are based on studies conducted by the ICMR in India for injectable contraceptives.

Pfizer is buying Hospira for approximately $15.23 billion, saying it is a good fit with its global established pharmaceutical business.

As durbar resumes functioning in Srinagar for the six-month stint, Kashmir is cool and normal.

Aurobindo Pharma said they may incur a revenue loss to the extent of $2 million per month till the issue remains unresolved.